Beam Therapeutics Inc (BEAM)
21.62
-1.12
(-4.93%)
USD |
NASDAQ |
Apr 25, 16:00
21.62
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Price to Book Value: 1.799 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.892 |
| April 23, 2024 | 1.953 |
| April 22, 2024 | 2.005 |
| April 19, 2024 | 1.989 |
| April 18, 2024 | 2.023 |
| April 17, 2024 | 2.023 |
| April 16, 2024 | 2.138 |
| April 15, 2024 | 2.138 |
| April 12, 2024 | 2.158 |
| April 11, 2024 | 2.269 |
| April 10, 2024 | 2.252 |
| April 09, 2024 | 2.440 |
| April 08, 2024 | 2.397 |
| April 05, 2024 | 2.347 |
| April 04, 2024 | 2.416 |
| April 03, 2024 | 2.470 |
| April 02, 2024 | 2.542 |
| April 01, 2024 | 2.718 |
| March 28, 2024 | 2.749 |
| March 27, 2024 | 2.826 |
| March 26, 2024 | 2.764 |
| March 25, 2024 | 2.803 |
| March 22, 2024 | 2.798 |
| March 21, 2024 | 2.908 |
| March 20, 2024 | 2.902 |
| Date | Value |
|---|---|
| March 19, 2024 | 2.899 |
| March 18, 2024 | 2.835 |
| March 15, 2024 | 2.946 |
| March 14, 2024 | 2.880 |
| March 13, 2024 | 3.110 |
| March 12, 2024 | 2.979 |
| March 11, 2024 | 3.043 |
| March 08, 2024 | 3.123 |
| March 07, 2024 | 3.076 |
| March 06, 2024 | 3.185 |
| March 05, 2024 | 3.204 |
| March 04, 2024 | 3.182 |
| March 01, 2024 | 3.315 |
| February 29, 2024 | 3.286 |
| February 28, 2024 | 3.629 |
| February 27, 2024 | 3.750 |
| February 26, 2024 | 2.979 |
| February 23, 2024 | 2.828 |
| February 22, 2024 | 2.791 |
| February 21, 2024 | 2.643 |
| February 20, 2024 | 2.646 |
| February 16, 2024 | 2.737 |
| February 15, 2024 | 2.747 |
| February 14, 2024 | 2.603 |
| February 13, 2024 | 2.494 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.799
Minimum
Apr 25 2024
30.10
Maximum
Feb 08 2021
6.818
Average
4.749
Median
Apr 05 2022
Price to Book Value Benchmarks
| Eli Lilly and Co | 63.99 |
| Moderna Inc | 2.935 |
| Pfizer Inc | 1.603 |
| Editas Medicine Inc | 1.225 |
| Intellia Therapeutics Inc | 1.831 |
Price to Book Value Related Metrics
| PS Ratio | 4.415 |
| Price | 21.62 |
| Earnings Yield | -8.79% |
| Market Cap | 1.765B |